NuMedii

NuMedii Discovers and De-risks Effective New Drugs by Translating Large-scale Life Science Data into Therapies with Higher Probabilities of Success. The company's proprietary and dynamic big data technology, developed in Atul Butte's laboratory at Stanford University and exclusively licensed to NuMedii, encompasses hundreds of millions of human, biological, pharmacological, and clinical data points that the company has standardized and annotated. NuMedii integrates these data with proprietary network-based algorithms to identify drug candidates and biomarkers and predict disease efficacy.